Objective: Standard treatment in locally-advanced cervical cancer is external beam radiotherapy concomitant with platinum-based chemotherapy, followed by brachytherapy. The goal of our study was to determine whether an intensity modulated radiation therapy (IMRT) boost is feasible in patients unfit for brachytherapy. Methods: We retrospectively analyzed data of 25 patients unfit for brachytherapy with median age 55 years (range, 30-82) with locally-advanced/metastatic cervical cancer who underwent external beam radiotherapy to pelvis ±para-aortic lymph nodes and sequential IMRT boost between July 2014 and December 2017. Total dose of 45-50.4 Gy in 25-28 fractions (1.8 Gy/fraction) was administered to the cervix, uterus, parametria, ovaries, vaginal tissues (based on vaginal extension), involved lymph nodes, or relevant draining lymph-nodal groups. Para-aortic nodes were included if involved at radiological staging or if common iliac nodes were positive. The IMRT boost included all residual tumor after external beam radiotherapy identified on MRI. The Kaplan-Meier method was used to calculate 2 years' overall survival, 2 years' progression-free survival, and 2 years' local control. Overall survival- A nd progression-free survival were calculated considering the starting of radiotherapy or neo-adjuvant chemotherapy if prescribed, while local control was calculated from the end of radiotherapy. Results: Median radiation dose to pelvis ±para-aortic lymph nodes was 50.4 Gy (45-50.4), boost treatment was homogeneously performed to a total dose of 25 Gy in five fractions every other day. After a median follow-up of 26 months (range, 4-77), tumor persistence at cervix at 6 months from the end of radiotherapy or local recurrence occurred in five women (20%), eight (32%) experienced a further distant progression (two of them had also tumor persistence). Two-year local control and overall survival rates for all stages were 78% and 67%, respectively. According to Common Terminology Criteria for Adverse Events v.4 scoring criteria, 10 patients experienced gastrointestinal and/or genitourinary grade G1-2 acute toxicity. G2 rectal late toxicity requiring laser-coagulation was registered in two patients, there were no gastrointestinal and/or genitourinary acute or late toxicities≥G3. Conclusion: The combination of external beam radiotherapy and brachytherapy remains the standard of care, however our preliminary data show the feasibility of IMRT boost in terms of toxicity with promising results in terms of local control and overall survival.
Lazzari, R., Riva, G., Augugliaro, M., Vavassori, A., Dicuonzo, S., Cattani, F., et al. (2020). Intensity modulated radiation therapy boost in locally-advanced cervical cancer in the absence of brachytherapy. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 30, 607-612 [10.1136/ijgc-2019-000735].
|Citazione:||Lazzari, R., Riva, G., Augugliaro, M., Vavassori, A., Dicuonzo, S., Cattani, F., et al. (2020). Intensity modulated radiation therapy boost in locally-advanced cervical cancer in the absence of brachytherapy. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 30, 607-612 [10.1136/ijgc-2019-000735].|
|Tipo:||Articolo in rivista - Articolo scientifico|
|Carattere della pubblicazione:||Scientifica|
|Presenza di un coautore afferente ad Istituzioni straniere:||No|
|Titolo:||Intensity modulated radiation therapy boost in locally-advanced cervical cancer in the absence of brachytherapy|
|Autori:||Lazzari, R; Riva, G; Augugliaro, M; Vavassori, A; Dicuonzo, S; Cattani, F; Comi, S; Colombo, N; Jereczek-Fossa, B|
|Data di pubblicazione:||2020|
|Rivista:||INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1136/ijgc-2019-000735|
|Appare nelle tipologie:||01 - Articolo su rivista|